chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the vaccine and still got them/Suspected vaccination failure; still got them; still having nerve pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 3 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-MAY-2022 Reporters comment:  The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. After receiving Shingles vaccine, the patient still got shingles. The patient stated that, you were correct, 3 months after receiving Shingles vaccine, he/she was still having nerve pain till the time of reporting Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not be possible as contact details were not provided.
First ever mastitis occurrence after Pfizer dose 1 on my left breast after receiving dose 1 in my left arm. second occurrence of mastitis within 36 hours of second Pfizer dose in my left arm also in my left breast.
Pt. black-out for about 10 seconds, rolling of the eyes, no involuntary movements, loss of tone or postictal sleeping. P/O 100% B/P 69/39 Pulse rate 73-81 Pt. was awake, alert, interactive and walking at the time of leaving the clinic. Pt instructions: water, rest and increase salt intake for today.
Headache; Chills; Fever; Put her in bed for couple of days; This case was reported by a other health professional via sales rep and described the occurrence of headache in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 26th june,2020) and Shingrix with an associated reaction of headache (For tolerance to 1st dose and other events refer case US2020AMR209258).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced headache, chills, fever and activities of daily living impaired. On an unknown date, the outcome of the headache, chills, fever and activities of daily living impaired were unknown.   It was unknown if the reporter considered the headache, chills, fever and activities of daily living impaired to be related to Shingrix.  Additional details were as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  HCP reported that patient received the 2nd dose of shingrix and experienced evnts like headache,chills and fever just recently patient did not experience the same side effects and Head ache was the major complaint. It was reported that patient received the 1st dose of shingrix on 26th june,2020 and Patient had grade 3 side effects from 1st dose of Shingrix that put her in bed for a couple days. It was also reported that patient experienced same events after the 2nd dose which was occured before with the 1st dose. Events were milder as compared to the first dose. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR209258:1st dose
Pain in arms; Body aches; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Pain in arms), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
woke up the next morning with shingles on my right breast, arm pit, and shoulder blade.; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: FE3590), dose 2 via an unspecified route of administration in arm left on 07Oct2021 at 18:30 (age at vaccination 43-year-old) as dose 2, single for covid-19 immunisation at Pharmacy or Drug Store. The patient had allergies with darvocet. Medical history included methylenetetrahydrofolate reductase gene and prothrombin level abnormal from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received any other medications included gabapentin and fluoxetine hcl taken for an unspecified indication, start and stop date were not reported the patient received within 2 weeks of vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: 301308A), dose 1 via an unspecified route of administration in arm left on 16Sep2021 at 12:00 pm as dose 1, single for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced woke up the next morning with shingles on right breast, arm pit, and shoulder blade on 08Oct2021 at 06:30 am. The adverse event resulted to visit emergency room. Therapeutic measures included methylprednisolone tablets and valacyclovir HCL were taken for the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
THIRD VARICELLA VACCINE RECEIVED.  PREVIOUS DOSES ON CHILD GIVEN ON THESE DATES: 4/21/03, 04/18/2007
post herpetic neuralgia; balance issues; Information has been received from a lawyer regarding a case in litigation and referring to a patient (pt) of unknown age and gender. Information about the pt's concurrent conditions, medical history and concomitant medications was not reported. On an unknown date, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, reported as after receiving zoster vaccine live (ZOSTAVAX), the pt suffered postherpetic neuralgia and balance issues. As a result of these symptoms, the pt was seen and treated by medical providers and at the time of report was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using the suspect product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of the pt's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the suspect product, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered/not resolved. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of post herpetic neuralgia and balance disorder were considered to be disabling.
Onset of diarrhea, loss of appetite, chills, fatigue on 3rd day post vaccine. Symptoms lasted two days. I treated with 500 mg Tylenol every six hours. The third day the chills subsided. But on the 4th day, today, days chills and nausea returned. I have not been running measurable fever however.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions and allergies was unknown. Concomitant therapy included sterile diluent. On an unknown date the patient was vaccinated with improperly stored PROQUAD (rHA) (dose, units and frequency were unknown) (Lot# M046943 and expiration date 27-MAY-2018) at a temperature excursion from 14"C to -10"C (degree centigrade) (-13.5"C) for 1 hour 5 minutes. There was no previous temperature excursion. The call was because of a data logger. No adverse effects were reported. There was no product quality compliant reported. Lot number [M046943] has been verified to be a valid lot number for [measles, mumps, rubella and varicella (oka-merck) virus vaccine live].
Pain and limited motion of arm and shoulder.   Pain in right side of neck. Have sought physical therapy now in  4th week Prior periodic gerd has increased to a daily struggle with gerd on a  on and off low grade fever still persisting
Patient received Shingrix vaccine on 8/11/20. The vaccine was given approximately 2 inches down from the shoulder according to the pharmacist. The patient stated that she had pain at the time of injection, and the pharmacist recommended that the patient use an ice pack to help with swelling or pain at the site of the injection. The next day the patient reported to the pharmacist on duty that she was experiencing shoulder pain and immobility. The patient believed that the vaccine was injected too high in her arm. The pharmacist counseled the patient to take ibuprofen for pain and utilize ice packs. The patient stated she was seen in Employee Health, but there is no recorded encounter in the medical record to investigate further. She contacted her physicians office and stated she was unable to lift her right arm to shoulder height nor was she able to carry anything with it.  She was taking 800 mg Ibuprofen TID along with 1000 mg Tylenol BID and applying ice 4 times daily. They physician advised on Thursday  8/13 the patient should follow up if not resolved by Monday. No follow up shown in chart.
Diarrhea started day p/inject continued until 23AUG91; 10SEP FU 4th dose fever & swollen leg; 5th dose h/a & sl fever;
Swollen and painful lymph nodes in left armpit. Swelling lasted 2 days. Pain lasted 3 days. Symptoms were treated with Tylenol, Advil, and propping left arm up with a pillow to prevent pressure on under arm area.
10/02/21: Headache, sore arm, chills, R ear heaviness (temporary loss of hearing) 10/06/21: Headache (pressure headache mainly on L side of face) continued with temporary loss of hearing in R ear 10/10/21: Regained hearing sensation in R ear 11/01/22: Pressured headaches continued on and off about 3xs a week, frequent sensation of pain/cramping in hand, legs, and feet 12/01/22: Headaches continued about 3xs a week, pain and cramping in legs and feet. Hand pain about 3xs a week 01/06/22: MD appointment regarding symptoms. MRI and Labs were ordered. 01/27/22:  MRI of head 01/28/22: CT of neck 02/01/22: More labs 02/04/22: Biopsy/ultrasound 03/22/22: PPD, UA, and lab 3/23/22: CT of neck 04/15/22: Pending surgery of left lymph node
local reaction post meningococcal vaccine; This case was reported by a nurse via other manufacturer and described the occurrence of local reaction in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced local reaction. On an unknown date, the outcome of the local reaction was unknown.   It was unknown if the reporter considered the local reaction to be related to Bexsero.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced local reaction post meningococcal vaccine, Bexsero B. The reporter recognized she contacted wrong manufacturer and was looking up GlaxoSmithKline contact information to call to report. No further information provided.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020133267:
2nd Pfizer COVID vaccine 6/25/21 Hospitalized 11/8/21
1200- Pt. had 1st Moderna vaccine-approx. 30 seconds after injection, she complained of chest tightness and throat tingling. M.D. was informed and restored. Pt drove to an observation area and was observed for 30 min. 1210- Pt. was given 20mg Pepcid- P.O. Pt. refused Benadryl. relief of throat tingling. Chest tightness was init. at 2/10. after Pepcid and some relaxing-pressure was 1/10. the patient remained calm. Vital signs were stable throughout observation. Pt was very anxious naturally, due to recent diagnosis of R.A. and chostal chondiritis. the pt. was observed for a total of 30 minutes. She was seen by  two Dr's, she was released after 30 mins. 1215- tingling in throat has subsided. 1210 BP 130/78 P 100 Resp 20, lungs clear SPo2 97%. 1220 BP 118/84 P 75 Resp 20 SPo2 97%.
coldness; numbness with  extremities; sore throat; congested; shortness of breath; This is a spontaneous report from a non-contactable physician (patient). A 31-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on unknown date in Jan2021 at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient received the second dose of the covid vaccine on Friday. The patient had coldness, numbness with extremities within 2 hours. She was not sure if it was just in her head. Saturday she had sore throat, was congested and had some shortness of breath. "Today" the patient was still congested and still with some shortness of breath, the patient wanted know if she should get tested for covid. The events were assessed non-serious. The was outcome was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient inadvertently received a 4th dose of the vaccine; 3rd dose (booster) was previously administered on June 16, 2022
I am having vomiting and there is blood in it; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATEMESIS (I am having vomiting and there is blood in it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2021, the patient experienced HAEMATEMESIS (I am having vomiting and there is blood in it) (seriousness criterion medically significant). At the time of the report, HAEMATEMESIS (I am having vomiting and there is blood in it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. No further information is available for this case.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. No further information is available for this case.
Swelling, itching, pain at the injection site. Fever, chills, severe headache, nausea and dizziness.
HERPES ZOSTER FOLLOWING VARICELLA VACCINE.  REACTIVATION OF VACCINE STRAIN CONFIRMED BY PCR.  CASE HAD LOCALIZED RASH IN C7 DERMATOME WITH MILD PAIN.  TREATED WITH BENADRYL.  RASH RESOLVED WITHOUT COMPLICATION OR HOSPITALIZATION.
(R) arm cellulitis vs local allergic reaction to flu vaccine. (R) arm tender, erythemic and swollen. No pus noted, no drainage. Treated with Amoxicillin 400mg given BID PO, Septra suspension 12.5 ml BID.
1 week after admin of vaccine, Pt. developed fever, at highest of 101 F with slightly raised papules covering belly, back, arms, legs and face.
This spontaneous report was received on 12-NOV-2018 from a pharmacist regarding a patient, of unknown age and gender. No information was provided regarding the patient's medical history, concomitant medications, drug reactions, allergies or concurrent conditions reported at the time of this report. On 10-NOV-2018 the patient received a (the fourth dose) of GARDASIL 9 for prophylaxis (lot #N035032, expiration date 24-SEP-2020) (strength, anatomical location, route of administration were not reported). The reporter does not have the dates of administration, lot numbers and expiration dates of the previous three doses. At the time of this report, the causality assessment, the outcome and the action taken were unknown.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very mild symptoms), RASH MACULAR (Very red and blotchy), TENDERNESS (Arm is tender), PYREXIA (Mild fever around 100 degrees) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history is reported. Concomitant products included VITAMINS NOS for an unknown indication. On 13-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced VACCINATION COMPLICATION (very mild symptoms), TENDERNESS (Arm is tender), PYREXIA (Mild fever around 100 degrees) and CHILLS (Chills). On 16-Nov-2021, the patient experienced RASH MACULAR (Very red and blotchy), VACCINATION SITE RASH (Rash circle all around the injection site) and VACCINATION SITE ERYTHEMA (Today when woke up they have a red rash going from the injection site on her left arm.). The patient was treated with HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (very mild symptoms), RASH MACULAR (Very red and blotchy), TENDERNESS (Arm is tender), PYREXIA (Mild fever around 100 degrees), CHILLS (Chills), VACCINATION SITE RASH (Rash circle all around the injection site) and VACCINATION SITE ERYTHEMA (Today when woke up they have a red rash going from the injection site on her left arm.) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):In November 2021, Body temperature: high (High) around 100 degrees.This case was linked to MOD-2021-388764 (Patient Link).Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Follow up received contains no new information.
Pt recvd 3 doses of Engerix-B 12OCT90, 12NOV90, & 30MAY91; 13OCT90 pt exp anorexia for 1 wk; OCT90 pt also exp URI for 7 days; pt tx w/Amoxicillin; in addition it was determined that pt did not respond to the vax series;
4 hours, post vax, had abdominal pains and a steady pain in the lower left abdomen.
Patient developed erythema, hives, and itching of the upper arms, chest and face. Slight lip swelling after administration of PPSV23. Treated with 2 doses of BENADRYL 25 mg PO, symptoms improved.
pt recvd vax 2OCT95 & 7OCT95 pt devel 4-5 varicella-like lesions on legs & a few more during the next few days;No further details were provided;
Pt recv vax on 10/9/98; on 10/23/98 pt exp measles-like rash on trunk, limbs, right eye, joint pain, photophobia  Annual Follow-up received on 9/19/00 states that the pt continued to have burning pain in hands, feet and most joints. Some swelling in the joints was noted. Pain in the hips was elevated. Still unable to work due to severe pain and decreased ability to be on feet for any length of time.
Patient has been called about the Bivalent vaccine and will get that one in 2 months
overwhelmingly sick; nauseous/nauseousness; Light-headed; Headache; Flush sensation; Fever; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 18Feb2021 at 15:00 (Batch/Lot Number: EL8982) as dose 1, single (at the age of 68-years-old) for Covid-19 immunisation. Medical history included Thyroid (as reported). Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient experienced felt overwhelmingly sick, got very nauseous - nauseousness is so bad, light-headed, headache, flush sensation and fever. It was reported that the patient has had Thursday on 18Feb2021 (not clarified), and had the shot at 3 o' clock PM. It was reported that the patient usually has reaction to shots (unspecified shots) but was excited that it did not. So, she came with an ice pack and put it on her arm shortly when she got the shot just for ten seconds and then she moved her arm for like thirty minutes and she had no reaction with her arm. But, forty-eight hours later, on Saturday at 20Feb2021, at dinner as she got up from her chair as she was going for the second serving, she felt overwhelmingly sick and just wanted to lay down. She got very nauseous, very light-headed. Since that day, she has been consistently overwhelmed with nauseous, no vomiting but very nauseous. She has been having headache and it was like flush sensation like she has a slight fever and the flushing sensation stopped after a week. But that day, she still has nausea. She has gone to a doctor and he gave her some medication (treatment) for nauseousness and she finally used it last Saturday because the nauseousness was so bad and it helped her but she didn't take on Sunday, Monday or that day. She still has nauseousness but not severe like she can function and a rate to describe it was like she doesn't do vomit, like it is very similar to when a woman is pregnant and is nauseous. It was also reported that the patient had some blood work that day (09Mar2021). The patient was reportedly still experiencing the events, not as severe but she was and guessed that they were still persisting. Treatment for nausea included Zofran 4 mg on Saturday. Due date for the next shot was reportedly on 11Mar2021. Therapeutic measures were taken as a result of the event nauseous/nauseousness. The outcome of the events was not resolved.   No follow-up attempts are possible. No further information is expected.
Right side of her face red and swollen. Right eye swollen completely shut, trouble breathing, trouble sleeping, fidgety, non responsive, irritable, fever, mouth swollen and wheezing.